Interpreting the behavior of concentration–response curves of hyaluronidase inhibitors under DMSO-perturbed assay conditions
- 1 July 2016
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (13) , 3153-3157
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (26870217)
This publication has 32 references indexed in Scilit:
- Learning from our mistakes: The ‘unknown knowns’ in fragment screeningBioorganic & Medicinal Chemistry Letters, 2013
- Hyaluronidases, a group of glycosidases: Current and future perspectivesCarbohydrate Polymers, 2010
- Apparent activity in high-throughput screening: origins of compound-dependent assay interferenceCurrent Opinion in Chemical Biology, 2010
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in BioassaysJournal of Medicinal Chemistry, 2010
- The magic glue hyaluronan and its eraser hyaluronidase: A biological overviewLife Sciences, 2007
- Hyaluronidases: Their Genomics, Structures, and Mechanisms of ActionChemical Reviews, 2006
- Nonleadlikeness and leadlikeness in biochemical screeningDrug Discovery Today, 2003
- A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput ScreeningJournal of Medicinal Chemistry, 2002
- Inhibitors of the hyaluronidasesMatrix Biology, 2002
- Development of a Virtual Screening Method for Identification of “Frequent Hitters” in Compound LibrariesJournal of Medicinal Chemistry, 2001